Peiwei Wang

913 total citations
37 papers, 751 citations indexed

About

Peiwei Wang is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Peiwei Wang has authored 37 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Cancer Research and 9 papers in Immunology. Recurrent topics in Peiwei Wang's work include MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (8 papers) and Ginseng Biological Effects and Applications (6 papers). Peiwei Wang is often cited by papers focused on MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (8 papers) and Ginseng Biological Effects and Applications (6 papers). Peiwei Wang collaborates with scholars based in China, United States and Germany. Peiwei Wang's co-authors include Jingang Cui, Qinbo Yang, Xiaoye Du, Wenjian Wang, Teng Zhang, Minqi Xiong, Teng Zhang, Chenglin Jia, Wenjian Wang and Yu Chen and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Scientific Reports.

In The Last Decade

Peiwei Wang

34 papers receiving 746 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peiwei Wang China 16 479 202 96 93 88 37 751
Jingang Cui China 16 511 1.1× 198 1.0× 94 1.0× 106 1.1× 96 1.1× 39 825
Yan Lei China 17 567 1.2× 323 1.6× 64 0.7× 69 0.7× 63 0.7× 59 919
Yanbin Gao China 16 446 0.9× 206 1.0× 77 0.8× 66 0.7× 48 0.5× 29 788
Yingdong Lu China 15 462 1.0× 117 0.6× 150 1.6× 47 0.5× 63 0.7× 28 871
Yanni Lv China 17 387 0.8× 114 0.6× 34 0.4× 76 0.8× 94 1.1× 39 728
Danli Yang China 17 305 0.6× 101 0.5× 89 0.9× 110 1.2× 47 0.5× 31 604
Minglu Liang China 20 441 0.9× 185 0.9× 104 1.1× 47 0.5× 118 1.3× 52 884
Jinghua Zhang China 18 426 0.9× 136 0.7× 52 0.5× 51 0.5× 120 1.4× 41 765
Huifeng Hao China 14 354 0.7× 141 0.7× 95 1.0× 60 0.6× 132 1.5× 35 863
Man Xu China 17 355 0.7× 103 0.5× 166 1.7× 47 0.5× 53 0.6× 29 713

Countries citing papers authored by Peiwei Wang

Since Specialization
Citations

This map shows the geographic impact of Peiwei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peiwei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peiwei Wang more than expected).

Fields of papers citing papers by Peiwei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peiwei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peiwei Wang. The network helps show where Peiwei Wang may publish in the future.

Co-authorship network of co-authors of Peiwei Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Peiwei Wang. A scholar is included among the top collaborators of Peiwei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peiwei Wang. Peiwei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Li, Wen, Peiwei Wang, Ji Wang, et al.. (2025). Flux measurement of synchrotron radiation monochromatic X-ray in (6-70) keV. Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment. 1077. 170553–170553. 1 indexed citations
4.
Wang, Yujue, Jingang Cui, Peiwei Wang, et al.. (2024). Ginsenoside Rb1 mitigates acute catecholamine surge-induced myocardial injuries in part by suppressing STING-mediated macrophage activation. Biomedicine & Pharmacotherapy. 175. 116794–116794. 4 indexed citations
6.
Wang, Peiwei, Mengli Li, Yujue Wang, et al.. (2023). Cinnamic acid mitigates left ventricular hypertrophy and heart failure in part through modulating FTO-dependent N6-methyladenosine RNA modification in cardiomyocytes. Biomedicine & Pharmacotherapy. 165. 115168–115168. 15 indexed citations
7.
Wang, Shihua, Minqi Xiong, Mei Li, et al.. (2021). Dual Activity of Ginsenoside Rb1 in Hypertrophic Cardiomyocytes and Activated Macrophages: Implications for the Therapeutic Intervention of Cardiac Hypertrophy. Journal of Inflammation Research. Volume 14. 1789–1806. 16 indexed citations
8.
Feng, Jia, et al.. (2021). The Prognostic Value of ctDNA and bTMB on Immune Checkpoint Inhibitors in Human Cancer. Frontiers in Oncology. 11. 706910–706910. 14 indexed citations
9.
Wang, Peiwei, et al.. (2019). Key comparison BIPM.RI(I)-K2 of the air-kerma standards of the NIM, China, and the BIPM in low-energy x-rays. Metrologia. 56(1A). 6006–6006. 1 indexed citations
10.
Wang, Peiwei, Qinbo Yang, Xiaoye Du, Yu Chen, & Teng Zhang. (2019). Targeted regulation of Rell2 by microRNA-18a is implicated in the anti-metastatic effect of polyphyllin VI in breast cancer cells. European Journal of Pharmacology. 851. 161–173. 29 indexed citations
11.
Yang, Qinbo, Peiwei Wang, Xiaoye Du, et al.. (2018). Direct repression of IGF2 is implicated in the anti-angiogenic function of microRNA-210 in human retinal endothelial cells. Angiogenesis. 21(2). 313–323. 15 indexed citations
12.
Zhang, Yong, Dandan Wu, Jingang Cui, et al.. (2017). Luteolin-7-diglucuronide attenuates isoproterenol-induced myocardial injury and fibrosis in mice. Acta Pharmacologica Sinica. 38(3). 331–341. 58 indexed citations
13.
Bian, Minjuan, Xiaoye Du, Peiwei Wang, et al.. (2017). Combination of ginsenoside Rb1 and Rd protects the retina against bright light-induced degeneration. Scientific Reports. 7(1). 6015–6015. 19 indexed citations
14.
Bian, Minjuan, Xiaoye Du, Jingang Cui, et al.. (2016). Celastrol protects mouse retinas from bright light-induced degeneration through inhibition of oxidative stress and inflammation. Journal of Neuroinflammation. 13(1). 50–50. 44 indexed citations
15.
Yang, Qinbo, Peiwei Wang, Jingang Cui, et al.. (2016). Panax notoginseng saponins attenuate lung cancer growth in part through modulating the level of Met/miR-222 axis. Journal of Ethnopharmacology. 193. 255–265. 45 indexed citations
16.
He, Yanming, Hongjie Yang, Jingang Cui, et al.. (2015). Yiqi Huaju formula, a Chinese herbal medicine, reduces arterial pressure in salt-sensitive hypertension by inhibiting renin-angiotensin system activation. Molecular Medicine Reports. 12(4). 5321–5327. 10 indexed citations
17.
Yang, Qinbo, Xiaoyan Wang, Jingang Cui, et al.. (2014). Bidirectional regulation of angiogenesis and miR-18a expression by PNS in the mouse model of tumor complicated by myocardial ischemia. BMC Complementary and Alternative Medicine. 14(1). 183–183. 23 indexed citations
18.
Liu, Li, Jingang Cui, Qinbo Yang, et al.. (2014). Apocynin attenuates isoproterenol-induced myocardial injury and fibrogenesis. Biochemical and Biophysical Research Communications. 449(1). 55–61. 15 indexed citations
19.
Xiong, Minqi, Chenglin Jia, Jingang Cui, et al.. (2014). Shexiang Tongxin dropping pill attenuates atherosclerotic lesions in ApoE deficient mouse model. Journal of Ethnopharmacology. 159. 84–92. 29 indexed citations
20.
Yang, Qinbo, Chenglin Jia, Peiwei Wang, et al.. (2014). MicroRNA-505 identified from patients with essential hypertension impairs endothelial cell migration and tube formation. International Journal of Cardiology. 177(3). 925–934. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026